Informed consent for national registration of COVID-19 vaccination caused information bias of vaccine effectiveness estimates mostly in older adults: a bias correction study

被引:0
|
作者
van Werkhoven, Cornelis H. [1 ,2 ]
de Gier, Brechje [1 ]
McDonald, Scott A. [1 ]
de Melker, Hester E. [1 ]
Hahne, Susan J. M. [1 ]
van den Hof, Susan [1 ]
Knol, Mirjam J. [1 ]
机构
[1] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
关键词
Information bias; Misclassification; COVID-19; Vaccination; Vaccine effectiveness; Registry data; Key findings; MULTIPLE-IMPUTATION; MAXIMUM-LIKELIHOOD; MISCLASSIFICATION; REGRESSION;
D O I
10.1016/j.jclinepi.2024.111471
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Registration in the Dutch national COVID-19 vaccination register requires consent from the vaccinee. This causes misclassification of nonconsenting vaccinated persons as being unvaccinated. We quantified and corrected the resulting information bias in vaccine effecStudy Design and Setting: National data were used for the period dominated by the SARS-CoV-2 Delta variant (July 11 to November 15, 2021). VE ((1-relative risk)*100%) against COVID-19 hospitalization and intensive care unit (ICU) admission was estimated for individuals 12 to 49, 50 to 69, and >= 70 years of age using negative binomial regression. Anonymous data on vaccinations administered by the Municipal Health Services were used to determine informed consent percentages and estimate corrected VEs by iteratively imputing corrected vaccination status. Absolute bias was calculated as the absolute change in VE; relative bias as uncorrected/corrected relative risk. Results: A total of 8804 COVID-19 hospitalizations and 1692 COVID-19 ICU admissions were observed. The bias was largest in the 70+ age group where the nonconsent proportion was 7.0% and observed vaccination coverage was 87%: VE of primary vaccination against hospitalization changed from 75.5% (95% CI 73.5-77.4) before to 85.9% (95% CI 84.7-87.1) after correction (absolute bias -10.4 percentage point, relative bias 1.74). VE against ICU admission in this group was 88.7% (95% CI 86.2-90.8) before and 93.7% (95% CI 92.2-94.9) after correction (absolute bias 5.0 percentage point, relative bias 1.79). Conclusion: VE estimates can be substantially biased with modest nonconsent percentages for vaccination data registration. Data on covariate-specific nonconsent percentages should be available to correct this bias. (c) 2024 Published by Elsevier Inc.
引用
收藏
页数:11
相关论文
共 16 条
  • [1] Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data
    Kumwichar, Ponlagrit
    Poonsiri, Chittawan
    Botwright, Siobhan
    Sirichumroonwit, Natchalaikorn
    Loharjun, Bootsakorn
    Thawillarp, Supharerk
    Cheewaruangroj, Nontawit
    Chokchaisiripakdee, Amorn
    Teerawattananon, Yot
    Chongsuvivatwong, Virasakdi
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2024, 10
  • [2] COVID-19 vaccination effectiveness rates by week and sources of bias: a retrospective cohort study
    Ostropolets, Anna
    Hripcsak, George
    BMJ OPEN, 2022, 12 (08):
  • [3] COVID-19 vaccination status and testing rates in Finland-A potential cause for bias in observational vaccine effectiveness analysis
    Kuitunen, Ilari
    Uimonen, Mikko
    Seppala, Santeri J.
    Ponkilainen, Ville T.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 842 - 845
  • [4] Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors
    Doll, Margaret K.
    Pettigrew, Stacy M.
    Ma, Julia
    Verma, Aman
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E564 - E571
  • [5] Attitudes toward COVID-19 Vaccine Uptake: A Qualitative Study of Mostly Immigrant Racial/Ethnic Minority Older Adults
    Valero-Martinez, Carla
    Martinez-Rivera, Christopher
    Zhen-Duan, Jenny
    Fukuda, Marie
    Alegria, Margarita
    GERIATRICS, 2023, 8 (01)
  • [6] COVID-19 Booster Vaccination Bellwethers: Factors Predictive of Older Adults' Adoption of the Second Booster COVID-19 Vaccine in Israel: A Longitudinal Study
    Ben-David, Boaz M. M.
    Keisari, Shoshi
    Regev, Tali
    Palgi, Yuval
    JOURNAL OF APPLIED GERONTOLOGY, 2023, 42 (05) : 1113 - 1117
  • [7] Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
    Tamada, Yudai
    Takeuchi, Kenji
    Kusama, Taro
    Maeda, Megumi
    Murata, Fumiko
    Osaka, Ken
    Fukuda, Haruhisa
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [8] Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
    Yudai Tamada
    Kenji Takeuchi
    Taro Kusama
    Megumi Maeda
    Fumiko Murata
    Ken Osaka
    Haruhisa Fukuda
    BMC Infectious Diseases, 24
  • [9] COVID-19 Vaccine Hesitancy Among Older Adolescents and Young Adults: A National Cross-Sectional Study in China
    Zhang, Panpan
    Li, Yan
    Wang, Huanchun
    Luo, Liyan
    Wang, Ping
    Wang, Huimin
    Li, Qing
    Meng, Zejing
    Yang, Hui
    Liu, Yuanhong
    Zhou, Shiyue
    Li, Nan
    Zhang, Shengnan
    Bi, Jianzhong
    Zhang, Jiewen
    Zheng, Xiaolei
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [10] Vaccine hesitancy throughout the COVID-19 vaccination trajectory among immigrant and non-immigrant older adults: a cohort study
    Zlotnick, C.
    Castel, O. Cohen
    PUBLIC HEALTH, 2024, 234 : 105 - 111